Description
Cambridge Research Ostarine (MK-2866) contains 10mg x 60 Capsules. Enobosarm, also known as ostarine or MK-2866, is an investigational selective androgen receptor modulator (SARM) developed by GTx, Inc. for the treatment of conditions such as muscle wasting and osteoporosis, formerly under development by Merck & Company.
Formula: C19H14F3N3O3
Molar mass: 389.33 g/mol
ChemSpider ID: 9501667
Other names: GTx-024; MK-2866; Ostarine; S-22
Elimination half-life: 24 hours
Melting point: 132 to 136 °C (270 to 277 °F)
What is Cambridge Research Ostarine?
Ostarine, also known as MK-2866, GTx-024 or enobosarm, is considered a SARM, or Selective Androgen Receptor Modulator. It was developed in the mid 2000s to help combat bone and muscle wasting in people suffering from a range of debilitating diseases and ageing but is still being clinically researched and is not yet an approved drug.